Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients


ULUSOY C. A.

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Danimarka, ss.450

  • Basıldığı Ülke: Danimarka
  • Sayfa Sayıları: ss.450